The study is a prospective, multi-center, randomized blinded study to determine how repairing the subscapularis vs. not repairing the subscapularis when subjects are implanted with the AltiVate Reverse® Shoulder System for reverse total shoulder arthroplasty affects isometric and isokinetic internal rotational strength. It is hypothesized that patients in which the subscapularis is repaired will have improved postoperative isometric and isokinetic internal rotational strength.
Reverse shoulder arthroplasty (RSA) is performed to provide improvement in pain relief and restoration of function in patients with rotator cuff tear arthropathy and massive irreparable rotator cuff tears . Traditional total shoulder designs failed to address the unique mechanics of shoulders with deficient rotator cuffs. Different prosthesis designs exist for RSA, all of which increase the deltoid lever arm to provide a stable fulcrum for active elevation in a rotator cuff deficient shoulder. The Reverse® Shoulder Prosthesis (RSP®) (DJO Surgical) sought to address issues correlated to the Grammont design by lateralizing the center of rotation as well as utilizing a central compressive screw with a 5.0-mm peripheral locking screws for fixation and a glenosphere . Despite the success of the lateralized design, the effect of the repair of the subscapularis tendon during RSA on shoulder strength, range of motion, and shoulder function remains inconclusive. The rationale for repairing the subscapularis during RSA include anatomic preservation of a functioning rotator cuff muscle, an increased potential for internal rotation, better joint protection, and more stability. The reasoning for not repairing the subscapularis include that it may be biomechanically unfavorable for both the deltoid and the posterior rotator cuff, limiting the range of motion. As such, this randomized study aims to address if subscapularis repair impacts isometric and isokinetic internal rotational strength, with shoulder function and complications as secondary objectives, when patients are implanted with the AltiVate Reverse® device. The study will take place at multiple sites across the United States and will be managed by the DJO Surgical Clinical Affairs Department.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Utilizing fiberwire, high tensile strength suture
Reverse shoulder arthroplasty device
St. Luke's Hospital
St Louis, Missouri, United States
NYU Langone Center for Musculoskeletal Care
New York, New York, United States
Rothman Institute
Philadelphia, Pennsylvania, United States
Texas Orthopedic Group
Houston, Texas, United States
Change in isometric and isokinetic internal rotational strength of abductors
Maximal isometric strength of shoulder abductors and measured in kilograms using a force gauge
Time frame: 6 months, and 1, 2, 5 and 10 years
Change in isometric and isokinetic internal rotational strength of flexors
Maximal isometric strength of shoulder flexors measured in kilograms using a force gauge
Time frame: 6 months, and 1, 2, 5 and 10 years
Change in isometric and isokinetic internal rotational strength of internal rotators
Maximal isometric strength of shoulder measured internal rotators in kilograms using a force gauge
Time frame: 6 months, and 1, 2, 5 and 10 years
Change in isometric and isokinetic internal rotational strength of external rotators
Maximal isometric strength of shoulder measured external rotators in kilograms using a force gauge
Time frame: 6 months, and 1, 2, 5 and 10 years
To evaluate change in shoulder ROM with the AltiVate Reverse® Shoulder
Examine operative shoulder active forward elevation
Time frame: 6 months, and 1, 2, 5 and 10 years
To evaluate change in shoulder ROM with the AltiVate Reverse® Shoulder
Examine operative shoulder active abduction
Time frame: 6 months, and 1, 2, 5 and 10 years
To evaluate change in shoulder ROM with the AltiVate Reverse® Shoulder
Examine operative shoulder active external rotation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Masking
SINGLE
Enrollment
200
Time frame: 6 months, and 1, 2, 5 and 10 years
To evaluate change in shoulder ROM with the AltiVate Reverse® Shoulder
Examine operative shoulder active internal rotation
Time frame: 6 months, and 1, 2, 5 and 10 years
To evaluate change in shoulder functionality with the AltiVate Reverse® Shoulder
Examine change in ASES score
Time frame: 6 weeks,6 months, and 1, 2, 5 and 10 years
To evaluate change in shoulder functionality with the AltiVate Reverse® Shoulder
Examine change in pain per ASES assessment
Time frame: 6 weeks, 6 months, and 1, 2, 5 and 10 years
To evaluate change in shoulder functionality with the AltiVate Reverse® Shoulder
Examine change in SST score
Time frame: 6 weeks,6 months, and 1, 2, 5 and 10 years
To evaluate change in general health with the AltiVate Reverse® Shoulder
Examine change in VR-12
Time frame: 6 weeks, 6 months, and 1, 2, 5 and 10 years
To evaluate change in the radiographs of AltiVate Reverse® Shoulder
Examine radiographic parameters
Time frame: 6 weeks, 6 months, and 1, 2, 5 and 10 years
To evaluate device survivorship of the AltiVate Reverse® Shoulder
Examine adverse events
Time frame: 6 weeks, 6 months, and 1, 2, 5 and 10 years